期刊文献+

碳酸镧在高磷血症中的应用 被引量:7

Application of Lanthanum Carbonate in Hyperphosphataemia Treatment
原文传递
导出
摘要 镧制剂能有效降低血清中磷的含量,而且不会引起肾性骨病和高钙血症,其有效性和安全性较好,是新型的磷结合剂。本文将重点介绍临床应用较多的镧制剂-碳酸镧。 Lanthanum agents can effectively decrease serum phosphorus levels,and can not attach the diseases of renal osteodystrophy and hypercalcemia.This article introduced the clinical application of lanthanum agents(lanthanum carbonate).
出处 《稀土》 EI CAS CSCD 北大核心 2011年第1期75-79,共5页 Chinese Rare Earths
基金 国家自然科学基金项目(20966007) 内蒙古自治区自然科学基金重大项目(20080404ZD10)
关键词 高磷血症 慢性肾衰竭 磷酸盐 磷结合剂 碳酸镧 hyperphosphataemia chronic renal failure phosphate phosphate binders lanthanum carbonate
  • 相关文献

参考文献43

  • 1王海燕,王梅.慢性肾脏病及透析的临床指南[M].北京:人民卫生出版社,2004:141-153.
  • 2Martin K,Gonzalez A.Strategies to minimize bone disease in renal failure[J].Am J Kidney Dis,2001,38:1430-1436.
  • 3Block G A,Port FK.Be-evaluation of risks associated with hyperphosphataemia and hyperparathyroidism in dialysis patients:recommendations for a change in management[J].AmJ Kidney Dis,2000,35(6):1226-1237.
  • 4Coodman W G,Goldin J,Kuizon B D,et al.Coronary-Artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J Med2000,342:1478-1483.
  • 5Shigematsu T,Kono T,Satoh K,et al Phosphate overload accelerates vascular calcium deposition in end-Stage renal disease patients[J].Nephrol Dial Transplant,2003,18(suppl 3):ⅲ86-ⅲ89.
  • 6Ganesh SK,Stack AG,Levin NW,et al.Association of elevated serum PO4,Ca×PO4 product,and parathyroid hormone with cardiac mortality risk in chronic hemodialy-Sis patients[J].J Am Soc Nephrol,2001,12:2131-2138.
  • 7Kestenbaum B,Sampson J N,Rudser K D,et al.Serum phosphate levels and mortality risk among people with chronic kidney disease[J].J Am Soc Nephrol,2005,16:520-528.
  • 8Spasovski G B.Bone health and vascular calcification re-Lationships in chronic kidney disease[J].International Urology and Nephrology,2007,39:1209-1216.
  • 9Hutchison A J,Barnett ME,Kwan JTC,et al.Long-Term Efficacy and Safety Profile of Lanthanum Carbonate:Results for Up to 6 Years of Treatment.Nephron[J].Clin Practice,2008,110(1):c15-c23.
  • 10Block G A,Hulbert-Shearon TE,Lebin NW,et al.Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients:A national study[J].Am J Kidney Dis,1998,31:607-617.

二级参考文献134

共引文献116

同被引文献105

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部